What does PHARMACIE DU PERRON CHÂTELET do?

PHARMACIE DU PERRON CHÂTELET is a pharmacy in Charleroi. Private Limited, started on 8 June 2022, 1 establishment.

What is the address of PHARMACIE DU PERRON CHÂTELET?

The registered office of PHARMACIE DU PERRON CHÂTELET is located at Rue de Marchiennes 4, 6044 Charleroi.

Is PHARMACIE DU PERRON CHÂTELET still active?

Yes. According to the CBE (17 September 2026) PHARMACIE DU PERRON CHÂTELET is active, legal situation “Normale toestand”, started on 8 June 2022.

Is PHARMACIE DU PERRON CHÂTELET registered on Peppol?

Yes, PHARMACIE DU PERRON CHÂTELET is registered on the Peppol network with ID 0208:0786902404.

What is the enterprise number of PHARMACIE DU PERRON CHÂTELET?

The enterprise number of PHARMACIE DU PERRON CHÂTELET is BE0786902404.

When was PHARMACIE DU PERRON CHÂTELET founded?

PHARMACIE DU PERRON CHÂTELET was founded on 8 June 2022.

Who are the directors of PHARMACIE DU PERRON CHÂTELET?

According to the 2025 annual accounts, the directors of PHARMACIE DU PERRON CHÂTELET are: LAURENCE FONTENELLE, GUILLAUME REGNIER.

Is PHARMACIE DU PERRON CHÂTELET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 June 2022; 3 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DU PERRON CHÂTELET make in 2025?

PHARMACIE DU PERRON CHÂTELET posted a profit after taxes of € 1,383 in financial year 2025.

What is the revenue of PHARMACIE DU PERRON CHÂTELET?

As a small company, PHARMACIE DU PERRON CHÂTELET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 23,502.

PHARMACIE DU PERRON CHÂTELET (Private Limited)

Dossier PHARMACIE DU PERRON CHÂTELET, printed on 17 September 2026 from databakkes.be/en/0786902404/pharmacie-du-perron-chatelet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE DU PERRON CHÂTELET from Charleroi, company number BE0786902404, closed financial year 2025 with a result of € 1,383 after tax. For that financial year PHARMACIE DU PERRON CHÂTELET recorded a gross margin of € 23,502 and equity of € 86,490. Compared with financial year 2024, the result moved from € -103 to € 1,383. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 86,490

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1,383

▲ still € 103 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 37,954

▲ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 86,490.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 623,756

▼ 12% vs 2024

€ 86,630 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Taxes

€ 466

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 38,353 Gross margin 2023: € 38,353 First fiscal year in the series	€ 24,113 Gross margin 2024: € 24,113 ▼ 37% vs 2023 (€ 38,353) Unfavourable step	€ 23,502 Gross margin 2025: € 23,502 ▼ 3% vs 2024 (€ 24,113) Unfavourable step	▼ 3%
Profit after taxes	€ 85,210 Profit after taxes 2023: € 85,210 First fiscal year in the series	€ -103 Profit after taxes 2024: € -103 ▼ € 85,313 vs 2023 (€ 85,210) Unfavourable step	€ 1,383 Profit after taxes 2025: € 1,383 ▲ € 1,486 vs 2024 (€ -103) Favourable step	▲ € 1,486
Equity	€ 85,210 Equity 2023: € 85,210 First fiscal year in the series	€ 85,107 Equity 2024: € 85,107 Unchanged (€ 85,210) Unfavourable step	€ 86,490 Equity 2025: € 86,490 ▲ 2% vs 2024 (€ 85,107) Favourable step	▲ 2%
Total debts	€ 1,179,128 Total debts 2023: € 1,179,128 First fiscal year in the series	€ 1,147,704 Total debts 2024: € 1,147,704 ▼ 3% vs 2023 (€ 1,179,128) Favourable step	€ 1,194,222 Total debts 2025: € 1,194,222 ▲ 4% vs 2024 (€ 1,147,704) Unfavourable step	▲ 4%
Cash	€ 36,669 Cash 2023: € 36,669 First fiscal year in the series	€ 21,634 Cash 2024: € 21,634 ▼ 41% vs 2023 (€ 36,669) Unfavourable step	€ 37,954 Cash 2025: € 37,954 ▲ 75% vs 2024 (€ 21,634) Favourable step	▲ 75%
Retained profit	€ 85,210 Retained profit 2023: € 85,210 First fiscal year in the series	€ 85,107 Retained profit 2024: € 85,107 Unchanged (€ 85,210) Unfavourable step	€ 86,490 Retained profit 2025: € 86,490 ▲ 2% vs 2024 (€ 85,107) Favourable step	▲ 2%
Bank debt	€ 789,051 Bank debt 2023: € 789,051 First fiscal year in the series	€ 707,704 Bank debt 2024: € 707,704 ▼ 10% vs 2023 (€ 789,051) Favourable step	€ 623,756 Bank debt 2025: € 623,756 ▼ 12% vs 2024 (€ 707,704) Favourable step	▼ 12%
Balance sheet total	€ 1,264,337 Balance sheet total 2023: € 1,264,337 First fiscal year in the series	€ 1,232,810 Balance sheet total 2024: € 1,232,810 ▼ 2% vs 2023 (€ 1,264,337) Unchanged	€ 1,280,712 Balance sheet total 2025: € 1,280,712 ▲ 4% vs 2024 (€ 1,232,810) Unchanged	▲ 4%

Key figures of PHARMACIE DU PERRON CHÂTELET, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DU PERRON CHÂTELET?

What happened at PHARMACIE DU PERRON CHÂTELET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 1,383. filed late Source: NBB ↗
Jun 8, 2022 New establishment in Châtelet. KBO
2022 LAURENCE FONTENELLE became a director. NBB
2022 GUILLAUME REGNIER became a director. NBB
Jun 8, 2022 Start of the company according to the CBE. KBO

In short

From € 85,210 profit in 2023 to € 1,383 profit in 2025.

Paid € 542 in corporate taxes since 2023.

Best year ever: 2023, with € 85,210 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DU PERRON CHÂTELET? We notify you, reason included.

Follow PHARMACIE DU PERRON CHÂTELET

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LAURENCE FONTENELLE

GUILLAUME REGNIER

PHARMACIE DU PERRON CHÂTELET

PHARMACIE YSABEL DEMARET 100%

Behind PHARMACIE DU PERRON CHÂTELET are LAURENCE FONTENELLE and GUILLAUME REGNIER. It owns 100% of PHARMACIE YSABEL DEMARET itself.

See the full network in the app

Directors

According to the 2025 annual accounts

LAURENCE FONTENELLE

Director

Also active at: FONTENELLE ET FILLE

since 2022

GUILLAUME REGNIER

Director

Also active at: GESTIPHAR, FONTENELLE ET FILLE, PHARMACIE DU RING

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Marchiennes 4

6044 Charleroi

2.332.501.590

Rue du Commerce 1

6200 Châtelet

Active since 8 June 2022

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

PHARMACIE HERMAN M.C.

€ 379,407 gross margin · 2025

GESTIPHAR same network

€ 533,843 gross margin · 2025

Y.C.A.

€ 70,372 gross margin · 2025

FONTENELLE ET FILLE same network

€ 42,512 gross margin · 2025

PHARMACIE YSABEL DEMARET same network

€ 227,700 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0786.902.404
VAT number: BE 0786.902.404
Registered office: Rue de Marchiennes 4, 6044 Charleroi
Names & denominations: PHARMACIE DU PERRON CHÂTELET
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 June 2022
Peppol: Active · Active since 26 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗